Clinical Study of TUTI-16 in HIV-1 Infected and Uninfected Subjects
NCT01144026
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infections
Interventions
BIOLOGICAL:
TUTI-16 (0.2mg)
BIOLOGICAL:
TUTI-16 (1.0 mg)
Sponsor
Thymon, LLC